Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)
Clinical trial NCT04439357 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439357
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-25
- Primary completion
- 2020-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.